180 related articles for article (PubMed ID: 17064663)
1. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
Zuo Y; Shields SK; Chakraborty C
Biochem Biophys Res Commun; 2006 Dec; 351(2):361-7. PubMed ID: 17064663
[TBL] [Abstract][Full Text] [Related]
2. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
Zuo Y; Wu Y; Chakraborty C
J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2-mediated migration of human trophoblast requires RAC1 and CDC42.
Nicola C; Lala PK; Chakraborty C
Biol Reprod; 2008 Jun; 78(6):976-82. PubMed ID: 18235104
[TBL] [Abstract][Full Text] [Related]
4. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
5. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
Shi HY; Stafford LJ; Liu Z; Liu M; Zhang M
Cell Motil Cytoskeleton; 2007 May; 64(5):338-46. PubMed ID: 17301947
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth.
Wang J; Rao Q; Wang M; Wei H; Xing H; Liu H; Wang Y; Tang K; Peng L; Tian Z; Wang J
Biochem Biophys Res Commun; 2009 Sep; 386(4):769-74. PubMed ID: 19563775
[TBL] [Abstract][Full Text] [Related]
7. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
Paradiso A; Cardone RA; Bellizzi A; Bagorda A; Guerra L; Tommasino M; Casavola V; Reshkin SJ
Breast Cancer Res; 2004; 6(6):R616-28. PubMed ID: 15535843
[TBL] [Abstract][Full Text] [Related]
8. Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells.
Koh MS; Moon A
Biochem Biophys Res Commun; 2011 Mar; 406(1):25-9. PubMed ID: 21281602
[TBL] [Abstract][Full Text] [Related]
9. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.
Yang C; Klein EA; Assoian RK; Kazanietz MG
Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
11. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
12. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
Lewis-Saravalli S; Campbell S; Claing A
Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
Kusama T; Mukai M; Tatsuta M; Nakamura H; Inoue M
Int J Oncol; 2006 Jul; 29(1):217-23. PubMed ID: 16773203
[TBL] [Abstract][Full Text] [Related]
14. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells.
Zanca C; Cozzolino F; Quintavalle C; Di Costanzo S; Ricci-Vitiani L; Santoriello M; Monti M; Pucci P; Condorelli G
J Cell Physiol; 2010 Oct; 225(1):63-72. PubMed ID: 20648624
[TBL] [Abstract][Full Text] [Related]
15. Radixin regulates cell migration and cell-cell adhesion through Rac1.
Valderrama F; Thevapala S; Ridley AJ
J Cell Sci; 2012 Jul; 125(Pt 14):3310-9. PubMed ID: 22467863
[TBL] [Abstract][Full Text] [Related]
16. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion.
Chan AY; Coniglio SJ; Chuang YY; Michaelson D; Knaus UG; Philips MR; Symons M
Oncogene; 2005 Nov; 24(53):7821-9. PubMed ID: 16027728
[TBL] [Abstract][Full Text] [Related]
17. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
Zhu Y; Shen T; Liu J; Zheng J; Zhang Y; Xu R; Sun C; Du J; Chen Y; Gu L
Cell Signal; 2013 May; 25(5):1075-85. PubMed ID: 23353182
[TBL] [Abstract][Full Text] [Related]
18. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
[TBL] [Abstract][Full Text] [Related]
19. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
Zhang Y; Han G; Fan B; Zhou Y; Zhou X; Wei L; Zhang J
Eur J Pharmacol; 2009 Mar; 606(1-3):172-9. PubMed ID: 19171136
[TBL] [Abstract][Full Text] [Related]
20. Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.
Pennisi PA; Barr V; Nunez NP; Stannard B; Le Roith D
Cancer Res; 2002 Nov; 62(22):6529-37. PubMed ID: 12438247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
